IQVIA Holdings Operating Income Over Time
| IQV Stock | USD 186.91 15.63 7.72% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out IQVIA Holdings Performance and IQVIA Holdings Correlation. What growth prospects exist in Life Sciences Tools & Services sector? Can IQVIA capture new markets? Factors like these will boost the valuation of IQVIA Holdings. Market participants price IQVIA higher when confident in its future expansion prospects. Valuation analysis balances hard financial data with qualitative growth assessments. While each IQVIA Holdings valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Quarterly Earnings Growth 0.245 | Earnings Share 7.27 | Revenue Per Share | Quarterly Revenue Growth 0.052 | Return On Assets |
IQVIA Holdings's market price often diverges from its book value, the accounting figure shown on IQVIA's balance sheet. Smart investors calculate IQVIA Holdings' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. Since IQVIA Holdings' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IQVIA Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if IQVIA Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IQVIA Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare IQVIA Holdings and related stocks such as ResMed Inc, Agilent Technologies, and Alcon AG Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RMD | 700 K | 294.4 M | 354.8 M | 405.1 M | 409.2 M | 429 M | 425.8 M | 541.8 M | 579.3 M | 809.7 M | 903.7 M | 1 B | 1.1 B | 1.3 B | 1.7 B | 1.9 B | 2 B |
| A | 442 M | 1.1 B | 386 M | 419 M | 522 M | 615 M | 841 M | 904 M | 941 M | 846 M | 1.3 B | 1.6 B | 1.4 B | 1.5 B | 1.5 B | 1.7 B | 1.8 B |
| ALC | 1.2 B | 401.1 M | 401.1 M | 401.1 M | 401.1 M | 401.1 M | 10 M | (77 M) | (248 M) | (187 M) | (482 M) | 580 M | 672 M | 1 B | 1.4 B | 1.6 B | 1.7 B |
| MTD | 70.7 M | 380.7 M | 423.3 M | 450.4 M | 476.9 M | 513.7 M | 540.2 M | 609.9 M | 683 M | 728.4 M | 784 M | 994.7 M | 1.1 B | 1.2 B | 1.1 B | 1.3 B | 1.4 B |
| GEHC | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2.7 B | 2.8 B | 2.5 B | 2.4 B | 2.6 B | 3 B | 2.8 B |
| CAH | 8.4 M | 1.8 B | 996 M | 1.9 B | 2.2 B | 2.5 B | 2.1 B | 126 M | 2.1 B | (4.1 B) | 472 M | (607 M) | 752 M | 1.2 B | 2.3 B | 2.6 B | 2.7 B |
| WAT | 56.4 M | 528.6 M | 511.5 M | 517.3 M | 517.9 M | 567.5 M | 625 M | 662.2 M | 739.8 M | 708.5 M | 645.5 M | 821.7 M | 873.4 M | 817.7 M | 826.4 M | 950.3 M | 479 M |
| ILMN | (5.9 M) | 199.5 M | 200.8 M | 134.1 M | 514.7 M | 613 M | 587 M | 606 M | 883 M | 985 M | 393 M | (123 M) | (4.2 B) | (1.1 B) | (833 M) | (749.7 M) | (712.2 M) |
| HLN | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 897 M | 1.6 B | 1.6 B | 1.8 B | 2 B | 2.2 B | 2.5 B | 1.9 B |
IQVIA Holdings and related stocks such as ResMed Inc, Agilent Technologies, and Alcon AG Operating Income description
Operating Income is the amount of profit realized from IQVIA Holdings operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of IQVIA Holdings is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| IQVIA Holdings | IQV |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 2400 Ellis Road, |
| Exchange | New York Stock Exchange |
USD 186.91
Additional Tools for IQVIA Stock Analysis
When running IQVIA Holdings' price analysis, check to measure IQVIA Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IQVIA Holdings is operating at the current time. Most of IQVIA Holdings' value examination focuses on studying past and present price action to predict the probability of IQVIA Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IQVIA Holdings' price. Additionally, you may evaluate how the addition of IQVIA Holdings to your portfolios can decrease your overall portfolio volatility.